Skip to main content Back to Top
Advertisement

9/17/2019

Testosterone Cypionate Injection

Products Affected - Description

    • Depo-Testosterone intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, 1 count, NDC 00409-6557-01
    • Depo-Testosterone intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, NDC 00009-0347-02
    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00009-0417-01
    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00009-0417-02
    • Testosterone cypionate intramuscular injection, Cipla USA, 100 mg/mL, 10 mL vial, 1 count, NDC 69097-0536-37
    • Testosterone cypionate intramuscular injection, Cipla USA, 200 mg/mL, 1 mL vial, 1 count, NDC 69097-0537-31
    • Testosterone cypionate intramuscular injection, Cipla USA, 200 mg/mL, 10 mL vial, 1 count, NDC 69097-0537-37
    • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 1 mL vial, 1 count, NDC 00143-9659-01
    • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 10 mL vial, 1 count, NDC 00143-9726-01
    • Testosterone cypionate intramuscular injection, Perrigo, 200 mg/mL, 1 mL vial, 1 count, NDC 00574-0820-01
    • Testosterone cypionate intramuscular injection, Perrigo, 200 mg/mL, 10 mL vial, 1 count, NDC 00574-0820-10

Reason for the Shortage

    • Cipla has testosterone cypionate injection on back order because the company is changing NDC numbers.
    • Hikma and Perrigo did not provide a reason for the shortage.
    • Pfizer did not provide a reason for the shortage of Depo-Testosterone.
    • Sun Pharma has testosterone cypionate injection available.

Available Products

    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00409-6562-01
    • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00409-6562-20
    • Testosterone cypionate intramuscular injection, Sun Pharma, 100 mg/mL, 10 mL vial, 1 count, NDC 62756-0017-40
    • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 1 mL vial, 1 count, NDC 62756-0015-40
    • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 10 mL vial, 1 count, NDC 62756-0016-40

Estimated Resupply Dates

    • Cipla has testosterone cypionate injection on back order and the company cannot estimate a release date.
    • Hikma has testosterone cypionate 200 mg/mL 1 mL vials on allocation. The 200 mg/mL 10 mL vials are on back order and the company estimates a release date in mid- to late-November 2019.
    • Perrigo has testosterone cypionate 200 mg/mL 1 mL vials on intermittent back order and the company is releasing supplies as they become available. The 200 mg/mL 10 mL vials are on back order and the company cannot estimate a release date.
    • Pfizer has Depo-Testosterone 200 mg/mL 1 mL vials on intermittent back order and the company is releasing supplies as they become available. The 100 mg/mL 10 mL vials and 200 mg/mL 10 mL (NDC 00009-0417-02) vials are available in limited supply.

Updated

Updated September 17, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins